The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

Author： Akuffo Emma   Davis John   Fox Steven   Gloger Israel   Hosford David   Kinsey Emma   Jones Neil   Nock Christina   Roses Allen   Saunders Ann   Mark Skehel J.   Smith Marjorie   Cutler Paul  

Publisher： Informa Healthcare

ISSN： 1366-5804

Source： Biomarkers, Vol.13, Iss.6, 2008-09, pp. : 618-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers of oxidative stress are significantly elevated in Down syndrome - Diet and oxidative stress: A novel synthesis of epidemiological data on Alzheimer's disease

By Jovanovic S.V.   Clements D.   MacLeod K.  

Free Radical Biology and Medicine, Vol. 25, Iss. 9, 1998-12 ,pp. : 1044-1048

Elsevier

Access to resources Recommend Favorite

Computer-aided discovery of novel non-peptide inhibitors against amyloid-beta (Aβ) peptide aggregation for treating Alzheimer's disease

By Zhou Zheng-Li   Ho Yih   Liu Hsuan-Liang   Elumalai Pavadai   Chen Wei-Hsi  

Molecular Simulation, Vol. 41, Iss. 8, 2015-05 ,pp. : 622-632

Taylor & Francis Ltd

Access to resources Recommend Favorite

Gantenerumab for the treatment of Alzheimer's disease

By Delrieu Julien   Ousset Pierre Jean   Vellas Bruno  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 1077-1086

Informa Healthcare

Access to resources Recommend Favorite

Plasma Metabolome Signature in Patients with Early-stage Parkinson Disease

By  

Current Metabolomics, Vol. 6, Iss. 1, 2018-01 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite

The Quest for Novel Biomarkers in Early Diagnosis of Diabetic Neuropathy

By  

Current Proteomics, Vol. 14, Iss. 2, 2017-04 ,pp. : 86-99

Bentham Science Publishers

Access to resources Recommend Favorite